Safety and effectiveness of tolvaptan for fluid management after pediatric cardiovascular surgery
Yuzo Katayama1, Tsukasa Ozawa2, Noritsugu Shiono2
1Division of Cardiovascular Surgery, Department of Surgery, Toho University Omori Medical Center, 6-11 Omori-Nishi, Ota-ku, Tokyo, Japan. yuuzou.katayama@med.toho-u.ac.jp.
Insights
Tolvaptan effectively managed fluid retention in pediatric heart surgery patients. This treatment increased urine output and reduced diuretic needs without affecting electrolytes, showing it
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Pharmacology
Background:
- Postoperative fluid retention is a significant concern following open heart surgery, particularly in pediatric patients, due to inflammatory responses and increased vascular permeability from cardiopulmonary bypass.
- Effective fluid management strategies are crucial for optimizing outcomes in these vulnerable patients.
Purpose of the Study:
- To evaluate the safety and efficacy of tolvaptan in managing postoperative fluid retention in children undergoing congenital heart surgery.
- To compare the effects of tolvaptan combined with conventional diuretics against diuretics alone.
Main Methods:
- A retrospective study involving 43 pediatric patients who underwent open heart surgery.
- Patients were divided into two groups: one receiving conventional oral diuretics and the other receiving conventional diuretics plus a single dose of tolvaptan (0.45 mg/kg).
- Data on urinary output, additional diuretic requirements, central venous pressure, and electrolyte levels were collected and compared between groups.
Main Results:
- The tolvaptan group showed a significant increase in urinary output (54.3 ± 4.5 mL/kg) compared to the control group (47.3 ± 19.1 mL/kg; p=0.043).
- Patients receiving tolvaptan required significantly less additional intravenous diuretic medication (0.26 ± 0.23 mg/kg) versus the control group (0.62 ± 0.48 mg/kg; p=0.001).
- A smaller decrease in central venous pressure was observed in the tolvaptan group (1.3 ± 2.7 mmHg) compared to the control group (1.9 ± 3.8 mmHg; p=0.019).
- Electrolyte concentrations in blood and urine remained comparable between the two groups, indicating no significant adverse effects.
Conclusions:
- Tolvaptan, when added to conventional diuretic therapy, is an effective and safe option for managing postoperative fluid retention in pediatric patients after congenital heart surgery.
- The findings suggest that tolvaptan can help optimize fluid balance and reduce the need for additional diuretic interventions without compromising electrolyte homeostasis.
Background:
Postoperative fluid management is important after open heart surgery, because cardiopulmonary bypass evokes an abnormal inflammatory response and increases vascular permeability, especially in pediatric patients. We assessed the safety and effectiveness of tolvaptan for management of postoperative fluid retention after congenital heart surgery.
Methods And Results:
This retrospective study analyzed data from 43 children with uncomplicated congenital heart disease who underwent open heart surgery between September 2013 and August 2016. The patients were divided into two groups. Group N (n = 18; September 2013 through May 2014) received the conventional oral diuretics alone, and Group T (n = 25; June 2014 through August 2016) received a single dose of tolvaptan (0.45 mg/kg) in addition to the conventional oral diuretic therapy. Data were collected, while patients who received intensive care were assessed and compared between groups. Add-on tolvaptan use was associated with increased urinary output standardized by body weight (54.3 ± 4.5 vs 47.3 ± 19.1 mL/kg; p = 0.043), decreased additional intravenous diuretic dose standardized by body weight (0.26 ± 0.23 vs 0.62 ± 0.48 mg/kg; p = 0.001), and a smaller decrease in central venous pressure (1.3 ± 2.7 vs 1.9 ± 3.8 mmHg; p = 0.019). Laboratory analysis showed that electrolyte concentrations in blood and urine did not significantly differ between groups.
Conclusions:
Tolvaptan appears to be effective and safe for management of postoperative fluid retention after congenital heart surgery.
More Related Videos
Related Concept Videos
Acute Kidney Injury VI: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pharmacokinetics in Pediatric Patients: Drug Distribution
Hemodialysis III: Nursing Management


